S-Bank Fund Management Ltd
Source: SEC Form 13F · as of Mar 2026S-Bank Fund Management Ltd holds 19 biotech & pharma companies tracked by BioSniper, totaling $36.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$36.3M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 20,538 | $18.9M |
| MRKMerck & Co., Inc. | 29,976 | $3.6M |
| JNJJOHNSON & JOHNSON | 9,346 | $2.3M |
| ABBVAbbVie Inc. | 7,956 | $1.7M |
| RPRXRoyalty Pharma plc | 29,862 | $1.4M |
| ZTSZoetis Inc. | 11,052 | $1.3M |
| BMYBRISTOL MYERS SQUIBB CO | 14,911 | $904K |
| ABTABBOTT LABORATORIES | 8,565 | $879K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,000 | $812K |
| AMGNAMGEN INC | 2,272 | $799K |
| ARRYARRAY BIOPHARMA INC | 108,715 | $786K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,377 | $615K |
| WSTWest Pharmaceutical Services Inc. | 2,141 | $537K |
| REGNREGENERON PHARMACEUTICALS, INC. | 594 | $459K |
| IDXXIDEXX LABORATORIES INC /DE | 740 | $416K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,235 | $409K |
| IQVIQVIA Holdings Inc. | 1,009 | $172K |
| NBIXNEUROCRINE BIOSCIENCES INC | 885 | $117K |
| GILDGILEAD SCIENCES, INC. | 809 | $113K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.